Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ
Closed
Oct 6, 2026
Day's Range
8.7552 wk Range
0.1100Overview - ASBP - Aspire Biopharma Holdings, Inc.
Key Statistics
Valuation
Enterprise Value
147.31K
P/E (Trailing)
‪-0.01‬
PEG Ratio
‪0.00018‬
Price / Sales (TTM)
‪126.09‬
Price / Book
‪0.96‬
EV / EBITDA
‪-0.0095‬
Profitability
Gross Margin
‪-47.67%‬
Profit Margin
‪-1.87%‬
Operating Margin
‪-3,880.58%‬
Return on Assets
‪60.57%‬
Return on Equity
‪-1,032.14%‬
Ownership
Shares Outstanding
1.29M
Float
1.11M
Short % of Shares Outstanding
‪2.49%‬
Held by Insiders
‪20.10%‬
Held by Institutions
‪3.36%‬
Price stats
Beta
‪0.17‬
50-Day Avg
‪8.05‬
200-Day Avg
‪4.39‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ASBP - Aspire Biopharma Holdings, Inc.
Peers - ASBP - Aspire Biopharma Holdings, Inc.
Peer Comparison
Compared with companies in Auto Parts listed on NASDAQ.
Profile Summary - ASBP - Aspire Biopharma Holdings, Inc.
About
Aspire Biopharma Holdings, Inc. is a biopharmaceutical company focused on developing and marketing sublingual delivery technologies for drugs, nutraceuticals, and supplements. Its platform is designed to improve how active ingredients are absorbed by bypassing the gastrointestinal tract, with applications centered on…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
